Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06197243 · ClinicalTrials.gov registry record · NA
Augmenting Benzodiazepine Receptor Agonist Deprescribing With Acupuncture and Yoga Among Older Adults
A NA study of Anxiety and Insomnia, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
- 1
- Study location
NCT06197243: Completed NA study of Anxiety and Insomnia, sponsored by Vanderbilt University Medical Center.
NCT06197243 is a NA study of Anxiety and Insomnia that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 23 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06197243, a NA study of Anxiety and Insomnia, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
- 1
- Study location
Study Summary
The main purpose of this 12-week study is to see if a new combination of treatments can help older adults reduce benzodiazepine or related medication use. The treatment combination consists of 1) medical provider visits to gradually reduce the medication dose over 12 weeks, 2) acupuncture treatments, and 3) private yoga classes. Participants will be offered weekly visits for 12 weeks to receive combined treatments. Participants will be provided surveys before, during, and after the study to learn about their experience of the treatments. At the end of the study, participants will be invited to participate in a focus group to learn about their experience in the study.
Primary Outcome
Dose of BRZA for patients will be measured at baseline, 4, 8, and 12 weeks
Conditions Studied
Interventions
- OTHER Acupuncture
- OTHER Yoga
- OTHER Deprescribing
Study Locations (1)
Tennessee
- Osher Center for Integrative Health at Vanderbilt - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2023-12-14 |
| Est. Completion | 2025-05-23 |
| Phase | NA |
What the finished NCT06197243 record still lists
NCT06197243 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (95% lower).
The record links to 4 conditions, with Anxiety appearing as the primary indexed condition, and to 3 interventions - of which Acupuncture is the first listed.
NCT06197243 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT06197243 about?
NCT06197243 is a clinical study titled "Augmenting Benzodiazepine Receptor Agonist Deprescribing With Acupuncture and Yoga Among Older Adults". The main purpose of this 12-week study is to see if a new combination of treatments can help older adults reduce benzodiazepine or related medication use. The treatment combination consists of 1) medical provider visits to gradually reduce the medication dose over 12 weeks, 2) acupuncture treatments...
What is the current status of trial NCT06197243?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2023-12-14. Estimated completion is 2025-05-23.
What conditions does trial NCT06197243 study?
This clinical trial studies the following conditions: Anxiety, Insomnia, Benzodiazepine, Deprescription.
What interventions are being tested in trial NCT06197243?
The interventions under investigation include: Acupuncture (OTHER), Yoga (OTHER), Deprescribing (OTHER).
Who is sponsoring clinical trial NCT06197243?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06197243 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anxiety
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06197243's enrollment target sits among peer trials
23 321st of 364 higher than 43 of 364 other Anxiety trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Digital Intervention for Physical Activity
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
-
Personalized Feedback Intervention for Latinx Drinkers With Anxiety
RECRUITING · NA
-
Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI